Retina

Real-world study confirms faricimab’s efficacy in patients with nAMD

Faricimab offers comparable efficacy and safety to current treatments for neovascular age-related macular degeneration (nAMD), while showing increased durability, according to real-world data presented at EURETINA Congress 2023. This multi-center, prospective study delved included 670 eyes from 584 patients diagnosed with nAMD. The investigation encompassed both treatment-naïve individuals and those...